Zhang Jie, Liu Zhongtao, Zhou Shujing, Teng Yang, Zhang Xiangyu, Li Jinjing
Pharmacy College, Jiamusi university, Jiamusi 154007, China.
ACS Omega. 2020 Dec 1;5(49):31525-31534. doi: 10.1021/acsomega.0c03325. eCollection 2020 Dec 15.
Based on the targeting of ferroferric oxide (FeO) and the drug-loading property of carbon nanotubes (CNTs), a novel Span-PEG-composited FeO-CNTs-DOX multifunctional ultrasound contrast agent was designed and applied to tumor lesions. In situ liquid phase synthesis was employed to prepare the FeO-CNTs magnetic targeting complex, and the physical method was used to obtain the FeO-CNTs-DOX complex by loading doxorubicin (DOX) onto FeO-CNTs. The targeted drug-loading complex FeO-CNTs-DOX was combined with the membrane material of Span-PEG by the acoustic vibration cavitation method. The maximum tolerance for Span-PEG-composited FeO-CNTs-DOX microbubbles was 450 times higher, which has good safety. The loading rate of DOX in the obtained composite microbubbles was 17.02%. The proliferation inhibition rate of Span-PEG-composited FeO-CNTs-DOX microbubbles on liver cancer SMMC-7721 cells reached 48.3%. Span-PEG-composited FeO-CNTs-DOX microbubbles could significantly enhance ultrasonic imaging and enrich at a specific location under an external magnetic field, and the extended imaging time could ensure the effective observation and diagnosis of lesions.
基于三氧化二铁(FeO)的靶向性和碳纳米管(CNTs)的载药特性,设计了一种新型的Span-PEG复合FeO-CNTs-DOX多功能超声造影剂并将其应用于肿瘤病灶。采用原位液相合成法制备FeO-CNTs磁性靶向复合物,通过将阿霉素(DOX)负载到FeO-CNTs上,利用物理方法获得FeO-CNTs-DOX复合物。采用声振空化法将靶向载药复合物FeO-CNTs-DOX与Span-PEG膜材料复合。Span-PEG复合FeO-CNTs-DOX微泡的最大耐受量高450倍,具有良好的安全性。所得复合微泡中DOX的载药率为17.02%。Span-PEG复合FeO-CNTs-DOX微泡对肝癌SMMC-7721细胞的增殖抑制率达48.3%。Span-PEG复合FeO-CNTs-DOX微泡可显著增强超声成像,并在外加磁场作用下在特定位置富集,延长的成像时间可确保对病灶进行有效观察和诊断。
Colloids Surf B Biointerfaces. 2017-6-21
Artif Cells Nanomed Biotechnol. 2019-12
Pharmaceutics. 2023-2-26
J Nanobiotechnology. 2021-12-16
Nanomaterials (Basel). 2021-8-26
Front Chem. 2021-5-24
Front Med (Lausanne). 2021-5-4
Nanomedicine (Lond). 2019-11-21
AAPS PharmSciTech. 2019-1-7
Mater Sci Eng C Mater Biol Appl. 2016-11-1
Mater Sci Eng C Mater Biol Appl. 2016-10-1